Composite Tissue Adhesive as a hemostatic agent for parenchymatous trauma

D. J. Wilson; J. M. Kloss; J. J. Prior; D. H. Sierra; D. J. Terris

Composite Tissue Adhesive as a hemostatic agent for parenchymatous trauma

D. J. Wilson, J. M. Kloss, J. J. Prior, D. H. Sierra, D. J. Terris

Research output: Contribution to conference › Paper › peer-review

Abstract

Composite Tissue Adhesive (CTA) has been developed as a versatile hemostatic agent for the treatment of parenchymatous trauma. CTA is a fibrin-based composition formulated by adding fibrillar type I collagen to fibrinogen-Factor XIII solutions to alter the mechanical properties. CTA incorporates both collagen and fibrinogen in a formulation which is easy to administer and effective in quickly establishing hemostasis without any applied pressure. Because of its viscosity, CTA can be delivered in a controlled and traceable manner with surgical precision. A comparison of CTA with both cryoprecipitate and fibrin sealant has been conducted to evaluate their effects on hemostasis in a rat model.

Original language	English (US)
Pages	17
Number of pages	1
State	Published - 1996
Externally published	Yes
Event	Proceedings of the 1996 5th World Biomaterials Congress. Part 2 (of 2) - Toronto, Can Duration: May 29 1996 → Jun 2 1996

Other

Other	Proceedings of the 1996 5th World Biomaterials Congress. Part 2 (of 2)
City	Toronto, Can
Period	5/29/96 → 6/2/96

ASJC Scopus subject areas

General Materials Science

Cite this

@conference{0da22b0c46914326a69b9650547a56ae,

title = "Composite Tissue Adhesive as a hemostatic agent for parenchymatous trauma",

abstract = "Composite Tissue Adhesive (CTA) has been developed as a versatile hemostatic agent for the treatment of parenchymatous trauma. CTA is a fibrin-based composition formulated by adding fibrillar type I collagen to fibrinogen-Factor XIII solutions to alter the mechanical properties. CTA incorporates both collagen and fibrinogen in a formulation which is easy to administer and effective in quickly establishing hemostasis without any applied pressure. Because of its viscosity, CTA can be delivered in a controlled and traceable manner with surgical precision. A comparison of CTA with both cryoprecipitate and fibrin sealant has been conducted to evaluate their effects on hemostasis in a rat model.",

author = "Wilson, {D. J.} and Kloss, {J. M.} and Prior, {J. J.} and Sierra, {D. H.} and Terris, {D. J.}",

year = "1996",

language = "English (US)",

pages = "17",

note = "Proceedings of the 1996 5th World Biomaterials Congress. Part 2 (of 2) ; Conference date: 29-05-1996 Through 02-06-1996",

}

TY - CONF

T1 - Composite Tissue Adhesive as a hemostatic agent for parenchymatous trauma

AU - Wilson, D. J.

AU - Kloss, J. M.

AU - Prior, J. J.

AU - Sierra, D. H.

AU - Terris, D. J.

PY - 1996

Y1 - 1996

N2 - Composite Tissue Adhesive (CTA) has been developed as a versatile hemostatic agent for the treatment of parenchymatous trauma. CTA is a fibrin-based composition formulated by adding fibrillar type I collagen to fibrinogen-Factor XIII solutions to alter the mechanical properties. CTA incorporates both collagen and fibrinogen in a formulation which is easy to administer and effective in quickly establishing hemostasis without any applied pressure. Because of its viscosity, CTA can be delivered in a controlled and traceable manner with surgical precision. A comparison of CTA with both cryoprecipitate and fibrin sealant has been conducted to evaluate their effects on hemostasis in a rat model.

AB - Composite Tissue Adhesive (CTA) has been developed as a versatile hemostatic agent for the treatment of parenchymatous trauma. CTA is a fibrin-based composition formulated by adding fibrillar type I collagen to fibrinogen-Factor XIII solutions to alter the mechanical properties. CTA incorporates both collagen and fibrinogen in a formulation which is easy to administer and effective in quickly establishing hemostasis without any applied pressure. Because of its viscosity, CTA can be delivered in a controlled and traceable manner with surgical precision. A comparison of CTA with both cryoprecipitate and fibrin sealant has been conducted to evaluate their effects on hemostasis in a rat model.

UR - http://www.scopus.com/inward/record.url?scp=0030420769&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030420769&partnerID=8YFLogxK

M3 - Paper

AN - SCOPUS:0030420769

SP - 17

T2 - Proceedings of the 1996 5th World Biomaterials Congress. Part 2 (of 2)

Y2 - 29 May 1996 through 2 June 1996

ER -

Composite Tissue Adhesive as a hemostatic agent for parenchymatous trauma

Abstract

Other

ASJC Scopus subject areas

Other files and links

Fingerprint

Cite this